Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 224

The DOI matches its Crossref record.

Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan

Ren, Bin, Yan, Feifei, Deng, Zhouming, Zhang, Sheng, Xiao, Lingfei, Wu, Meng, Cai, Lin·2020·Circulation

Abstract

COVID-19 ◼ venous thrombosisT he coronavirus disease 2019 (COVID-19) pandemic has caused >4 million infections and 280 000 deaths worldwide (as of May 13, 2020).The case fatality ratio in China (as of February 11, 2020) was 2.3%, but that number among hospitalized critical patients was 49.0%. 1 The reason for the high case fatality ratio in critical patients with COVID-19 is not completely clear.During the 2002 severe acute respiratory syndrome pandemic, the incidences of deep vein thrombosis (DVT) and pulmonary embolism were 20.5% and 11.4% in autopsy cases. 2 Whether thrombosis contributes to the high mortality of COVID-19 remains unclear.As the global fight against COVID-19 continues, our study examined how prevalent thrombosis formation is for patients with COVID-19.A cross-sectional study was carried out in 2 hospitals in Wuhan, China, from February 29, 2020 to March 2, 2020.Patients were enrolled from the intensive care unit of Zhongnan Hospital of Wuhan University and Leishenshan Hospital, a newly constructed hospital designated for COVID-19 in Wuhan.Patients with confirmed COVID-19 in intensive care unit treatment (excluding patients with prior DVT or recent surgery) received compression ultrasound examinations in the lower extremities.The examinations were performed at least twice by the experienced sonographer team blinded to patient clinical history.Deep veins from the inguinal ligament to the ankle, including the femoral vein, popliteal vein, posterior tibial vein, peroneal vein, and intermuscular vein in the calf, were examined.Laboratory findings were gathered at the first assessment after patients were admitted to the intensive care unit.The study was approved by the Medical Ethical Committee of Zhongnan Hospital of Wuhan University (approval 2020031).Oral consent was obtained from patients or direct relatives.For the enrolled 48 critically ill patients with COVID-19, the median age was 70 years (interquartile range, 62-80 years; Table ).All but 1 patient (with coagulation contradiction) received 30 to 40 mg low-molecular-weight heparin (subcutaneous injection once daily) as anticoagulation.Lower extremity DVTs were detected in 41 patients (85.4%), with 36 (75%) isolated distal DVTs and 5 (10.4%) proximal DVT.The APACHE II (Acute Physiology and Chronic Health Evaluation II) score was 16 (9-24).In terms of comorbidities, the numbers of patients with hypertension, diabetes mellitus, previous cardiovascular disease, and previous cerebrovascular disease were 19 (39.6%), 13 (27.1%),11 (22.9%), and 7 (14.6%),respectively.All patients exhibited abnormal levels of inflammatory indicators, including an elevation of neutrophil count and a reduction of lymphocyte count.Of the 29 patients who received mechanical ventilation, 18 had endotracheal intubation.The median levels of D-dimer in patients with no DVT, isolated distal DVT, and proximal DVT were 0.90 mg/L (0.51-3.10 mg/L), 5.31 mg/L (1.12-9.78mg/L), and 3.53 mg/L (1.87-11.64mg/L), respectively (P=0.09), which were above the superior limit.In terms of patient deaths, as of April 16, 2020, 2 patients (28.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.120.047407

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 224

Metadata

Authors
Ren, B., Yan, F., Deng, Z., Zhang, S., Xiao, L., Wu, M., & Cai, L.
Venue
Circulation
Published
2020-07-14
Volume
142
Issue
2
Pages
181-183
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W3024145639
Cited by
224
References
0
FWCI
6.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan. https://app.cochat.ai/papers/10.1161/circulationaha.120.047407
The paper
Ren, B., Yan, F., Deng, Z., Zhang, S., Xiao, L., Wu, M., & Cai, L. (2020). Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan. Circulation. https://doi.org/10.1161/circulationaha.120.047407

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.